Timothy Edwin Kelly Praxis Precision Medicines, Inc. (PRAX) insider trading activity
Timothy Edwin Kelly is Chief Financial Officer of Praxis Precision Medicines, Inc.. Currently has a direct ownership of 12,345 shares of PRAX, which is worth approximately $906,369. The most recent transaction as insider was on Nov 14, 2024, when has been sold 205 shares (Common Stock) at a price of $37.4 per share, resulting in proceeds of $7,667. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
12.3K
1.69%
3M change
78.75%
12M change
Total Value Held
$906,369
Timothy Edwin Kelly Transaction History
TEK
Timothy Edwin Kelly
Chief Financial Officer
Cambridge, MA